Company Profile
Nanogenics Limited
07636591•Private Limited With Share Capital
Get Full Access
17/05/2011
15 years
3
—
72110
low risk
Company Overview
Registration, classification & business activity
Nanogenics Limited (07636591) is a private limited with share capital incorporated on 17/05/2011 (15 years old) and registered in london, EC2N4BQ. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Nanogenics is an innovative, research-based biotechnology company that specialises in developing bespoke, peptide-based vectors for gene therapy. nanogenics is proud to introduce liptideᵀᴹ; an exciting custom-built delivery vehicle that can be modified to target different cell types and deliver diff...
Financial Overview
£47.4K
£34.3K
£13.0K
£0
Key Metrics
3
Directors
6
Shareholders
1
Patents
Board of Directors
Innovate Grants
This company received a grant of £346253.6 for Development Of A Breakthrough Anti-Fibrotic Gene Therapy To Improve Surgical Outcomes And Reduce Re-Admission Rates For Patients With Severe Glaucoma.. The project started on 01/11/2019 and ended on 31/01/2021.
Risk Assessment
low risk
International Score
Future Factor
good
Performance Rating